Smith & Nephew plc
SNN
Price:
$24.475
Market Cap:
$10.78B
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as wel...[Read more]
Industry
Medical - Devices
IPO Date
1999-11-16
Stock Exchange
NYSE
Ticker
SNN
PE Ratio
[34.96]
ROE
[5.85%]
Current Ratio
[2.51]
Dividend Yield
[3.80%]
Enterprise Value
[13.87B]
Dividend History
The ROE as of December 2024 (TTM) for Smith & Nephew plc (SNN) is 5.85%
According to Smith & Nephew plc’s latest financial reports and current stock price. The company's current ROE is 5.85%. This represents a change of 299.81% compared to the average of 1.46% of the last 4 quarters.
Smith & Nephew plc (SNN) Historical ROE (quarterly & annually)
How has SNN ROE performed in the past?
The mean historical ROE of Smith & Nephew plc over the last ten years is 11.15%. The current 5.85% ROE has changed -47.51% with respect to the historical average. Over the past ten years (40 quarters), SNN's ROE was at its highest in in the September 2016 quarter at 6.86%. The ROE was at its lowest in in the September 2022 quarter at 0.44%.
Average
11.15%
Median
11.00%
Minimum
4.24%
Maximum
19.81%
Smith & Nephew plc (SNN) ROE by Quarter and Year
Discovering the peaks and valleys of Smith & Nephew plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 91.61%
Maximum Annual ROE = 19.81%
Minimum Annual Increase = -54.94%
Minimum Annual ROE = 4.24%
| Year | ROE | Change |
|---|---|---|
| 2023 | 5.04% | 18.89% |
| 2022 | 4.24% | -54.94% |
| 2021 | 9.41% | 10.89% |
| 2020 | 8.49% | -27.29% |
| 2019 | 11.67% | -14.20% |
| 2018 | 13.60% | -17.64% |
| 2017 | 16.52% | -16.62% |
| 2016 | 19.81% | 91.61% |
| 2015 | 10.34% | -16.64% |
| 2014 | 12.40% | -9.74% |
Smith & Nephew plc (SNN) Average ROE
How has SNN ROE performed in the past?
The current ROE of Smith & Nephew plc (SNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.23%
5-year avg
7.77%
10-year avg
11.15%
Smith & Nephew plc (SNN) ROE vs. Peers
How is SNN’s ROE compared to its peers?
Smith & Nephew plc’s ROE is less than Cochlear Limited (19.70%), less than Integer Holdings Corporation (7.30%), greater than Conformis, Inc. (-65.24%), greater than Motus GI Holdings, Inc. (-1832.08%), greater than Orthofix Medical Inc. (-21.25%), less than NuVasive, Inc. (4.86%), greater than Glaukos Corporation (-26.64%), greater than Heska Corporation (-4.29%), less than Bruker Corporation (19.04%), less than Globus Medical, Inc. (2.29%), less than CONMED Corporation (15.04%), greater than Alphatec Holdings, Inc. (-351.82%), less than LivaNova PLC (1.88%), greater than iRhythm Technologies, Inc. (-127.85%), greater than OrthoPediatrics Corp. (-7.64%), greater than Paragon 28, Inc. (-38.77%),
| Company | ROE | Market cap |
|---|---|---|
| 19.70% | $11.98B | |
| 7.30% | $4.52B | |
| -65.24% | $17.88M | |
| -1832.08% | $639.00 | |
| -21.25% | $662.63M | |
| 4.86% | $2.08B | |
| -26.64% | $8.34B | |
| -4.29% | $1.31B | |
| 19.04% | $8.83B | |
| 2.29% | $11.37B | |
| 15.04% | $2.16B | |
| -351.82% | $1.31B | |
| 1.88% | $2.54B | |
| -127.85% | $2.80B | |
| -7.64% | $546.67M | |
| -38.77% | $859.81M |
Build a custom stock screener for Smith & Nephew plc (SNN) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Smith & Nephew plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Smith & Nephew plc (SNN) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Smith & Nephew plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Smith & Nephew plc's ROE?
How is the ROE calculated for Smith & Nephew plc (SNN)?
What is the highest ROE for Smith & Nephew plc (SNN)?
What is the 3-year average ROE for Smith & Nephew plc (SNN)?
What is the 5-year average ROE for Smith & Nephew plc (SNN)?
How does the current ROE for Smith & Nephew plc (SNN) compare to its historical average?